Clinical Trials in Boston

Showing 10861-10880 of 15,299 trials

Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder

NCT00790868

This is a 5-year double blind, randomized, controlled, trial conducted at three treatment sites, aimed at showing the acute and longer-term effects of DCS augmentation of exposure-based CBT for panic disorder relative to placebo augmentation. By demonstrating that DCS can enhance the results of even a brief treatment strategy, the investigators are seeking to validate an approach that fits well with the practice limitations and applications of CBT in effectiveness studies.

Panic Disorder

Boston University Charles River Campus180 participantsStarted Apr 2008

Hartford, Connecticut, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +1 more locations

TERMINATEDPhase 2< 1 mile

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

NCT00115349

The purpose of this study is to determine whether left ventricular function improves more rapidly with deferoxamine (DFO) and deferiprone (L1) combination therapy than with DFO monotherapy in patients with thalassemia and decreased ejection fractions. Secondary aims include evaluating changes in myocardial iron burden using T2\* and estimating the relative incidence and severity of chelator-induced toxicity.

Cardiovascular DiseasesHeart DiseasesBeta-Thalassemia

Carelon Research20 participantsStarted Jun 2005

Los Angeles, California, United States • Oakland, California, United States • Chicago, Illinois, United States +3 more locations

Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Find Trials by Condition in Boston

Third International Study on Mechanical Ventilation

Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Healthy Habits, Happy Homes: An Intervention to Improve Household Routines for Obesity Prevention

Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

An Intervention to Improve Adolescent Headache Self-management

The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial